drugset / Trial / NCT00680641

Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)

NCT00680641

Phase 4 Unknown 20 enrolled University of East Anglia
RandomizedCrossoverDouble-blindTreatment

Summary

To determine the effects of 2 months therapy with simvastatin 40mg once per day compared to placebo in a double-blind placebo-controlled study of patients with COPD.

Timeline

Start
2008-04
Primary completion
2011-02
Completion
2012-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Simvastatin Small molecule 40 mg

Indications